Fibroma MRI

Fibroma Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Fibroma from other Diseases
Natural History, Complications & Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
X Ray
CT
MRI
Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Case Studies
Case #1
Fibroma MRI On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Fibroma MRI All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Fibroma MRI
CDC on Fibroma MRI
Fibroma MRI in the news
Blogs on Fibroma MRI
Directions to Hospitals Treating Fibroma
Risk calculators and risk factors for Fibroma MRI

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]

Key MRI Findings in Fibroma

• Signal characteristics include
• T1: fibromas usually demonstrate homogeneous low signal intensity
• T2

• Fibromas appear as well-circumscribed masses with low signal intensity
• May contain scattered hyperintense areas representing oedema or cystic degeneration.
• A band of T2 hypointensity separating the tumour from the uterus on all imaging planes is also considered a characteristic feature

• T1 C+ (Gd): usually shows heterogenous enhancement

References

Template:WikiDoc Sources